Sign up for free to view insider transactions by individual.
Bear of the Day: Boston Scientific (BSX)
Boston Scientific (BSX) Is Back In The Spotlight, What Is Driving Attention?
Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls?
Boston Scientific (BSX) Stock May Be 38% Undervalued Following WATCHMAN Trial News
Boston Scientific Targets Long-Term Growth as Key Businesses Face Pressure Through 2027
Boston Scientific Corporation (BSX) Presents at Stifel 2026 Healthcare Conference 2026 Transcript
Podcast: Driving DBS access for Parkinson’s patients in the UK and Europe
Wall Street Analysts Look Bullish on Boston Scientific (BSX): Should You Buy?
S&P revises Boston Scientific outlook to negative on franchise pressures
Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Boston Scientific (BSX) Secures $455 Million For A Next Generation Heart Pump
Are Wall Street Analysts Bullish on Boston Scientific Stock?
Boston Scientific and Blackstone agree on $455m VITALYST heart pump deal
SIMPLAAFY study of the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device meets primary endpoints
Boston Scientific Consensus Price Target Lowered by 10.06% to $57.12
Jefferies Downgrades Boston Scientific to Hold from Buy
TD Cowen Downgrades Boston Scientific to Hold, Lowers Price Target to $46
Barclays Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $45
Cyberattack Fallout Could Be A Game Changer For Boston Scientific (BSX)
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.